PAX5 Gene: Paired Box 5 Transcription Factor

Key regulator of B-cell development and differentiation, frequently altered in B-cell acute lymphoblastic leukemia (B-ALL)

Gene Information Card

Symbol PAX5
Full Name Paired Box 5
Gene Type Protein coding
Chromosomal Location 9p13.2
NCBI Gene ID 5079 ncbi.nlm.nih.gov/gene/5079
Ensembl ID ENSG00000196092
UniProt ID Q02548
OMIM ID 167414
HGNC ID 8619
Aliases BSAP, PAX-5

Description

PAX5 (Paired Box 5) encodes a transcription factor essential for B-cell lineage commitment and maintenance. It is a member of the paired box (PAX) family and is expressed primarily in B-lymphocytes and the developing central nervous system. PAX5 activates B-cell-specific genes while repressing genes of alternative hematopoietic lineages. Somatic mutations and chromosomal rearrangements involving PAX5 are common in B-cell acute lymphoblastic leukemia (B-ALL), often leading to haploinsufficiency or dominant-negative effects.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
B-cell acute lymphoblastic leukemia (B-ALL) PAX5 mutations (missense, nonsense, frameshift, deletions) cause loss of function or dominant-negative effects, impairing B-cell differentiation and promoting leukemogenesis. PMID: 12419252, 19300479
Acute lymphoblastic leukemia (ALL) with PAX5 rearrangement Chromosomal translocations (e.g., PAX5-ETV6, PAX5-JAK2) generate fusion proteins that disrupt normal PAX5 activity. PMID: 17344846, 19300479
Lymphoma, non-Hodgkin PAX5 alterations are occasionally reported in mature B-cell lymphomas, contributing to aberrant B-cell development. PMID: 21415854

Expression Profile

Tissue Expression
Tissue nTPM level
Lymph node 45.2 High
Spleen 38.7 High
Bone marrow 32.1 High
Appendix 28.5 High
Brain (cerebellum) 5.3 Low
Testis 2.1 Low
Cell Line Expression
Cell Line nTPM Notes
Raji (Burkitt lymphoma) 62.4 B-cell line, high PAX5 expression
Daudi (Burkitt lymphoma) 58.1 B-cell line
K562 (chronic myeloid leukemia) 0.8 Non-B cell, low expression
HEK293 (embryonic kidney) 0.5 Non-hematopoietic, low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.547C>T (p.Arg183*) Nonsense ~2% in B-ALL Premature stop, loss of function
c.632_633del (p.Leu211fs) Frameshift ~1% in B-ALL Frameshift, loss of function
c.215G>A (p.Gly72Asp) Missense ~0.5% in B-ALL Reduced DNA binding, dominant-negative
PAX5-ETV6 fusion Translocation ~1% in B-ALL Fusion protein, impaired transcriptional activity
Mutation functional classification

Loss of Function (LOF)

Most PAX5 mutations in B-ALL result in loss of function (haploinsufficiency or complete loss), impairing B-cell differentiation and promoting leukemogenesis.

Gain of Function (GOF)

Rare; some PAX5 fusions (e.g., PAX5-JAK2) may exhibit gain-of-function via constitutive kinase activation.

Dominant Negative (DN)

Certain missense mutations (e.g., p.Gly72Asp) produce proteins that interfere with wild-type PAX5 function, acting as dominant-negative inhibitors.

Pathways

B cell receptor signaling pathway (Reactome: R-HSA-983705)
Transcriptional regulation by PAX5 (Reactome: R-HSA-8939243)
Development of B lymphocytes (KEGG: hsa04662)

Protein Summary

PAX5 (BSAP) is a 391-amino acid transcription factor containing a paired box DNA-binding domain and a partial homeodomain. It is critical for B-cell identity, activating B-cell-specific genes (e.g., CD19, CD79A) and repressing non-B lineage genes. PAX5 also plays roles in neural development. In cancer, loss or alteration of PAX5 function is a hallmark of B-ALL, with mutations occurring in approximately 30% of cases.

Related Products

Product name Cat.No. Species Gene ID
PAX5 Knockout HEK293 Cell Line EDJ-KQ3392 Human 5079 Details Get a Quote
PAX5 Knockout HeLa Cell Line EDJ-KQ54084 Human 5079 Details Get a Quote
PAX5 Knockout A-549 Cell Line EDJ-KQ62572 Human 5079 Details Get a Quote
PAX5 Knockout HCT 116 Cell Line EDJ-KQ71042 Human 5079 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: